EUVIMEDEUVIMED entdecken
Crossref

Phenolic Hydroxyl-Containing Lipid Nanoparticles Enable Codelivery of HPV Peptide Antigens and Manganese Adjuvant for Cancer Immunotherapy

Shuang Hou, Deling Zhou, Yi Zhang, Youming Li, Dang Fan, Yeqin Hu, Liyan Li, Changjiang Qin, Mingxue Li iD, Ming Li, Hong Liu iD, Yongming Chen iD

ACS Applied Bio Materials · 2026

DOI: 10.1021/acsabm.6c01833 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Applied Bio Materials, 2026. Verfasst von Shuang Hou und 11 weiteren Autor:innen. Beteiligte Einrichtung: Translational Medical Center of Huaihe Hospital, Henan University, Kaifeng475004, China. Hauptthemen laut MEDLINE: Nanoparticles, Manganese, Immunotherapy, Adjuvants, Immunologic. Die Arbeit nennt 39 Literaturangaben. Gefördert von: National Natural Science Foundation of China, National Key Research and Development Program of China, Henan Provincial Science and Technology Research Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Therapeutic peptide vaccines against HPV-associated cancers are often limited by insufficient immunogenicity and inefficient intracellular delivery. Here, we develop a phenolic hydroxyl-containing lipid nanoparticle (EMT@LNP) as a nanomedicine platform for the coordinated codelivery of HPV16 E6/E7 peptide antigens and manganese (Mn2+) adjuvant. Distinct from conventional electrostatic loading strategies, EMT@LNP exploits hydrogen-bonding interactions between phenolic hydroxyl groups and peptide antigens, enabling charge-independent loading of peptides with diverse physicochemical properties, while coordination interactions between phenolic moieties and Mn2+ allow the simultaneous incorporation of immunostimulatory adjuvants. This dual-interaction-driven design integrates antigen delivery and innate immune activation within a single nanostructure. Functionally, EMT@LNP enhances antigen uptake and promotes dendritic cell maturation, accompanied by activation of STING-associated signaling, as indicated by increased phosphorylation of STING, TBK1, and IRF3. In vivo, EMT@LNP facilitates efficient delivery to draining lymph nodes and prolongs antigen retention following intramuscular administration. In a therapeutic TC-1 tumor model, EMT@LNP elicits potent antitumor immune responses, characterized by enhanced CD8+ T-cell infiltration and reduced immunosuppressive cell populations, leading to significant tumor growth inhibition without observable systemic toxicity. Collectively, this study presents a nanobiotechnology strategy that combines charge-independent peptide loading with metal-ion-mediated immune activation, providing a versatile and potentially translatable platform for therapeutic vaccination against HPV-associated malignancies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NanoparticlesManganeseImmunotherapyAdjuvants, ImmunologicLipidsBiocompatible MaterialsPapillomavirus E7 ProteinsAntigens, ViralAnimalsMiceOncogene Proteins, ViralHumansProtein Subunit VaccinesParticle SizeFemaleMaterials TestingRepressor ProteinsNanovaccinesMice, Inbred C57BL

Stichwörter der Autor:innen

HPV16 E6/E7cancer nanovaccinelipid nanoparticleslymph node deliverymanganese adjuvanttumor immunotherapy

Substanzen

ManganeseAdjuvants, ImmunologicLipidsBiocompatible MaterialsPapillomavirus E7 ProteinsOncogene Proteins, Viraloncogene protein E7, Human papillomavirus type 16Protein Subunit VaccinesE6 protein, Human papillomavirus type 16Antigens, Viral

Autor:innen und Institutionen

  • Translational Medical Center of Huaihe Hospital, Henan University, Kaifeng475004, China.
  • Henan Key Laboratory of Preparation and Applications of Polyoxometalates, College of Chemistry and Molecular Sciences, Henan University, Kaifeng475004, China.
  • College of Chemistry and Molecular Sciences, Henan University , Kaifeng475004, China.
  • MAXVAX Bio-tech Co., Ltd., Chengdu610200, China.
  • Department of Immunology, School of Basic Medical Science, Henan University, Kaifeng475004, China.
  • Department of Gastrointestinal Surgery, Huaihe Hospital of Henan University, Kaifeng475004, China.

ORCID-Profile: Mingxue Li, Hong Liu, Yongming Chen

Förderung

  • National Natural Science Foundation of China
  • National Key Research and Development Program of China
  • Henan Provincial Science and Technology Research Project
  • Science and Technology Innovation Talents in Universities of Henan Province

Zitieren

APA

Hou, S., Zhou, D., Zhang, Y., Li, Y., Fan, D., Hu, Y., Li, L., Qin, C., Li, M., Li, M., Liu, H., & Chen, Y. (2026). Phenolic Hydroxyl-Containing Lipid Nanoparticles Enable Codelivery of HPV Peptide Antigens and Manganese Adjuvant for Cancer Immunotherapy. ACS Applied Bio Materials. https://doi.org/10.1021/acsabm.6c01833

Vancouver

Hou S, Zhou D, Zhang Y, Li Y, Fan D, Hu Y, et al. Phenolic Hydroxyl-Containing Lipid Nanoparticles Enable Codelivery of HPV Peptide Antigens and Manganese Adjuvant for Cancer Immunotherapy. ACS Applied Bio Materials. 2026. doi:10.1021/acsabm.6c01833

BibTeX
@article{Hou2026,
  author = {Hou, Shuang and Zhou, Deling and Zhang, Yi and Li, Youming and Fan, Dang and Hu, Yeqin and Li, Liyan and Qin, Changjiang and Li, Mingxue and Li, Ming and Liu, Hong and Chen, Yongming},
  title = {Phenolic Hydroxyl-Containing Lipid Nanoparticles Enable Codelivery of HPV Peptide Antigens and Manganese Adjuvant for Cancer Immunotherapy},
  journal = {ACS Applied Bio Materials},
  year = {2026},
  doi = {10.1021/acsabm.6c01833}
}
Kostenlos starten →